Interview with Dr. Lauro Moretto, Executive Director, SINDUSFARMA – Sindicato…
When we interviewed you four years ago, you gave us a picture of the industry. How has that picture changed since then? We can start with the regulatory picture. In…
Address: Praia de Botafogo 501 1° Andar Bloco Corcovado 22250-040 Rio de Janeiro – RJ,Brazil
Tel: 55 21 3266 6200
Web: http://www1.actelion.com.br/br/index.page
In 2002, Actelion opened its first office in Latin America. Brazil was chosen as the venue due to different factors. The country is a medical centre in the region and is endowed with considerable structure, hospital and medical science. Brazil also possesses a strong political and social framework and is projected to be an important partner in international decisions, not only due its specific significance, such as increasing the performance of its economy.
In addition, it has development programs and conducts scientific and technological research.
Due to its growth potential in pharmaceuticals and its status as one of the largest research centers of reference in the continent, Brazil was chosen to as base of operations for Actelion in Latin America.
Tracleer, Zavesca
When we interviewed you four years ago, you gave us a picture of the industry. How has that picture changed since then? We can start with the regulatory picture. In…
Hypermarcas is a huge, diversified corporation that sells everything from shampoo, to medicine. Would you consider it more of a consumer goods company that happens to sell pharmaceuticals, or the…
Many readers may find it counterintuitive that SINDUSFARMA, which represents syndicates, is organized by a team of management executives. Historically, these two groups tend to be in opposition. Can you…
What would you recommend in terms of increasing the competitiveness and growth of the Brazilian pharmaceutical industry? The Brazilian pharmaceutical industry needs to improve its R&D capabilities. I personally think…
We know the raw data already in the Brazilian market and the number changes since our last visit in 2007 – but how would you interpret these changes into a…
Minister Pimentel recently released the BrasilMaior plan, whose slogan is “Innovate to compete. Compete to grow.” How would you recommend the government innovate, compete, and grow in the pharmaceutical industry…
You’ve made some bold moves in your career – from the head of vaccines in Latin America, followed by stints in Colombia, Puerto Rico, and finally Brazil. What brought you…
We asked Mr. Santos regarding his recommendations to help the government innovate, compete, and grow in the pharmaceutical industry here in Brazil on the Human Genetic Therapies side. Is there…
Many international CROs entered Brazil in the past few years, whereas Quintiles made its first move in Brazil in 1996. What was the strategic decision behind entering Brazil at that…
PGS is a member of ABRACRO, but is in a unique position as both a CRO and a service provider to CROs and pharmaceutical companies. Can you elaborate on the…
The government recently released the ‘BrasilMaior’ plan, whose slogan is “Innovate to compete. Compete to grow.” How would you recommend the government innovate, compete, and grow in the pharmaceutical industry…
Besins finally arrived in Brazil in 2010. In addition to introducing the company to the market, would you also elaborate on the strategic motivation behind this decision? Besins Healthcare is…
See our Cookie Privacy Policy Here
